|
|
Regulation of the Microglial Neuroimmune Response by Long Non-Coding RNAs |
| 1R15AI156879-01A1 |
|
NIAID |
2022 |
|
|
Alu dsRNAs as adjuvants for influenza vaccines |
| 1R21AI164107-01A1 |
|
NIAID |
2022 |
|
|
Identification of cellular heme transport receptors that regulate T cell function |
| 1R21AI164722-01A1 |
|
NIAID |
2022 |
|
|
Combating chronic neuroinflammatory disorders by targeting NAC1 |
| 1R21AI167793-01A1 |
|
NIAID |
2022 |
|
|
IL-1R1, MMP-9, and EAE |
| 1R21AI169218-01 |
|
NIAID |
2022 |
|
|
Allograft inflammatory factor-1 and immune tolerance |
| 1R21AI171739-01 |
|
NIAID |
2022 |
|
|
B cell-targeted CAR-T treatment of CNS Autoimmunity |
| 1R21AI171994-01 |
|
NIAID |
2022 |
|
|
Human T cell Lymphotropic Virus Vaccine development |
| 1R41AI165061-01A1 |
|
NIAID |
2022 |
|
|
Novel immunotherapy against MOG antibody disease |
| 1R43AI172705-01 |
|
NIAID |
2022 |
|
|
STAT5 tetramerization in autoimmune-mediated neuroinflammation |
| 1R56AI167972-01 |
|
NIAID |
2022 |
